Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-6,page-paged-6,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

CLIENT NEWS

 

 

  • Relief Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG
    www.relieftherapeutics.com
  • Marinomed Biotech plans clinical trial with Carragelose nasal spray to investigate prevention of COVID-19 infection in frontline healthcare staff
    www.marinomed.com
  • Relief Selects CRO and CDMO for RLF-100TM in Europe
    www.relieftherapeutics.com
  • Abivax Receives “Best Technology Award” at the European Mediscience Awards 2020
    www.abivax.com
  • amcure GmbH: amcure and Hinova Pharmaceuticals enter into an exclusive license agreement for the development, manufacturing and commercialization of AMC303 in oncology in the Greater China region
    www.amcure.com
  • 4basebio AG reports first nine months of 2020 financial results
    www.4basebio.com
  • CEVEC signs agreement with Roche for the use of CEVEC’s ELEVECTA® Technology in gene therapy
    www.cevec.com
  • HepaRegeniX GmbH to deliver an oral presentation of preclinical results on a inhibition in liver regeneration at The Liver Meeting 2020
    www.heparegenix.com/
  • CatalYm GmbH: CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients
    www.catalym.com
  • Verona Pharma plc: Verona Pharma Announces November 2020 Virtual Investor Conference Participation
    www.veronapharma.com